Cipher Pharmaceuticals (CPH) News Today C$12.75 +0.18 (+1.43%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Analysts Offer Predictions for TSE:CPH Q1 EarningsMarch 28 at 1:29 AM | americanbankingnews.comWhat is Stifel Canada's Forecast for TSE:CPH Q1 Earnings?Cipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Equities researchers at Stifel Canada issued their Q1 2025 earnings per share estimates for Cipher Pharmaceuticals in a report released on Monday, March 24th. Stifel Canada analyst J. Keywood anticipates that the company will earMarch 27, 2025 | marketbeat.comHarold Morton Wolkin Sells 3,500 Shares of Cipher Pharmaceuticals Inc. (TSE:CPH) StockCipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the stock in a transaction on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total value of C$47,215.00.March 25, 2025 | marketbeat.comCipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in StockMarch 25, 2025 | insidertrades.comLeede Financial Weighs in on TSE:CPH FY2027 EarningsMarch 25, 2025 | americanbankingnews.comLeede Financial Estimates TSE:CPH FY2027 EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Equities researchers at Leede Financial issued their FY2027 earnings per share (EPS) estimates for shares of Cipher Pharmaceuticals in a report issued on Wednesday, March 19th. Leede Financial analyst D. Loe expects that the compMarch 24, 2025 | marketbeat.comFY2025 EPS Estimates for TSE:CPH Decreased by AnalystMarch 23, 2025 | americanbankingnews.comTSE:CPH FY2025 EPS Estimate Lowered by Leede FinancialCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Equities researchers at Leede Financial decreased their FY2025 earnings estimates for Cipher Pharmaceuticals in a report released on Wednesday, March 19th. Leede Financial analyst D. Loe now expects that the company will post earMarch 22, 2025 | marketbeat.comEarnings call transcript: Cipher Pharmaceuticals Q4 2024 sees stock surgeMarch 21, 2025 | uk.investing.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ResultsMarch 19, 2025 | theglobeandmail.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?March 17, 2025 | uk.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average - Here's WhyCipher Pharmaceuticals (TSE:CPH) Stock Passes Below 50 Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Crosses Below 50 Day Moving Average - Should You Sell?Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Below 50 Day Moving Average - Here's What HappenedFebruary 22, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Below 50-Day Moving Average - Here's What HappenedCipher Pharmaceuticals (TSE:CPH) Shares Cross Below Fifty Day Moving Average - Time to Sell?February 13, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below Fifty Day Moving Average - Here's What HappenedCipher Pharmaceuticals (TSE:CPH) Stock Passes Below Fifty Day Moving Average - Time to Sell?February 5, 2025 | marketbeat.comCipher Pharmaceuticals Inc. (TSE:CPH) most popular amongst individual investors who own 57%, insiders hold 42%February 4, 2025 | finance.yahoo.comThis Healthcare Stock Could Be the Best Investment of the DecadeJanuary 31, 2025 | msn.com1 Canadian Stock Ready to Start 2025 With a BangJanuary 30, 2025 | fool.ca5 Best-performing Canadian Pharma Stocks (Updated January 2025)January 11, 2025 | msn.comCipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Above 50 Day Moving Average - Here's What HappenedCipher Pharmaceuticals (TSE:CPH) Stock Crosses Above Fifty Day Moving Average - Here's WhyJanuary 10, 2025 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average - Time to Sell?Cipher Pharmaceuticals (TSE:CPH) Stock Passes Above Fifty Day Moving Average - Should You Sell?January 10, 2025 | marketbeat.comThose who invested in Cipher Pharmaceuticals (TSE:CPH) five years ago are up 883%December 25, 2024 | finance.yahoo.comStifel Canada Has Positive View of TSE:CPH FY2025 EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Investment analysts at Stifel Canada lifted their FY2025 EPS estimates for Cipher Pharmaceuticals in a research note issued to investors on Tuesday, December 3rd. Stifel Canada analyst J. Keywood now expects that the company willDecember 6, 2024 | marketbeat.comLeede Financial Analysts Cut Earnings Estimates for TSE:CPHCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Stock analysts at Leede Financial dropped their FY2025 earnings estimates for shares of Cipher Pharmaceuticals in a note issued to investors on Friday, November 8th. Leede Financial analyst D. Loe now anticipates that the companyNovember 11, 2024 | marketbeat.comCipher Pharmaceuticals Third Quarter 2024 Earnings: EPS Misses ExpectationsNovember 11, 2024 | uk.finance.yahoo.comCipher Pharmaceuticals Reports Third Quarter 2024 ResultsNovember 8, 2024 | theglobeandmail.comCipher Pharmaceuticals’ Revenue Soars After Natroba AcquisitionNovember 7, 2024 | markets.businessinsider.comWhat To Expect From Cipher Pharmaceuticals Inc (TSX:CPH) Q3 2024 EarningsNovember 7, 2024 | finance.yahoo.comEarnings To Watch: Cipher Pharmaceuticals Inc (TSX:CPH) Reports Q3 2024 ResultNovember 6, 2024 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference CallNovember 4, 2024 | finance.yahoo.comStifel Canada Issues Negative Estimate for TSE:CPH EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Research analysts at Stifel Canada lowered their Q3 2024 earnings estimates for Cipher Pharmaceuticals in a report released on Tuesday, October 22nd. Stifel Canada analyst J. Keywood now forecasts that the company will earn $0.03October 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) PT Raised to C$19.00 at Stifel NicolausStifel Nicolaus lifted their target price on Cipher Pharmaceuticals from C$17.00 to C$19.00 in a research note on Thursday.October 24, 2024 | marketbeat.comEquities Analysts Offer Predictions for TSE:CPH Q4 EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Equities research analysts at Stifel Canada raised their Q4 2024 earnings per share estimates for Cipher Pharmaceuticals in a report issued on Tuesday, October 22nd. Stifel Canada analyst J. Keywood now expects that the company wOctober 24, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Crosses Above 50 Day Moving Average - Here's WhyCipher Pharmaceuticals (TSE:CPH) Stock Price Passes Above 50 Day Moving Average - Should You Sell?October 4, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below Fifty Day Moving Average of $14.21Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average of $14.21September 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Rating Lowered by Leede FinancialLeede Financial downgraded shares of Cipher Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research note on Friday.September 17, 2024 | marketbeat.comCanadian Investment Regulatory Organization Trading Halt - CPHSeptember 14, 2024 | ca.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Shares Down 18.3% Cipher Pharmaceuticals (TSE:CPH) Stock Price Down 18.3%September 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $19.69Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $19.69August 29, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $16.60Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $16.60August 22, 2024 | marketbeat.comCipher Pharmaceuticals Inc (PHE.SG)August 17, 2024 | nz.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $14.63Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $14.63August 16, 2024 | marketbeat.comCipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You ThinkAugust 15, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Rating Increased to Strong-Buy at Stifel CanadaStifel Canada raised shares of Cipher Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a research note on Monday.August 14, 2024 | marketbeat.comStifel Canada Comments on Cipher Pharmaceuticals Inc.'s Q3 2024 Earnings (TSE:CPH)Cipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Analysts at Stifel Canada boosted their Q3 2024 earnings estimates for Cipher Pharmaceuticals in a research report issued to clients and investors on Monday, August 12th. Stifel Canada analyst J. Keywood now expects that the compAugust 14, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Lifted to "Buy" at Stifel NicolausStifel Nicolaus raised Cipher Pharmaceuticals from a "hold" rating to a "buy" rating and raised their target price for the company from C$9.50 to C$16.00 in a report on Tuesday.August 13, 2024 | marketbeat.comCipher Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 12, 2024 | finance.yahoo.comCipher Pharmaceuticals earnings preview: what Wall Street is expectingAugust 9, 2024 | markets.businessinsider.comCipher Pharmaceuticals Reports Second Quarter 2024 ResultsAugust 9, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $13.25Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $13.25August 6, 2024 | marketbeat.com Remove Ads Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address CPH Media Mentions By Week CPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPH News Sentiment▼1.000.82▲Average Medical News Sentiment CPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPH Articles This Week▼101▲CPH Articles Average Week Remove Ads Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRON News TLRY News GUD News ACB News WEED News OGI News CRDL News RX News HLS News SUGR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CPH) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
